prikaz prve stranice dokumenta Auditing HIV testing rates across Europe: results from the HIDES 2 Study
  Download
PDF 286.81 KB
Scientific paper - Original scientific paper
Auditing HIV testing rates across Europe: results from the HIDES 2 Study
PLoS ONE, 10 (2015), 11; e0140845. https://doi.org/10.1371/journal.pone.0140845
Raben, D.; Mocroft, A.; Rayment, M.; Mitsura, V. M.; Hadziosmanovic, V.; Sthoeger, Z. M.; Palfreeman, A.; Morris, S.; Kutsyna, G.; Vassilenko, A.; Minton, J.; Necsoi, C.; Estrada, V. P.; Grzeszczuk, A.; Svedhem Johansson, V.; Begovac, Josip; Ong, E. L. C.; Cabié, A.; Ajana, F.; Celesia, B. M.; Maltez, F.; Kitchen, M.; Comi, L.; Dragsted, U. B.; Clumeck, N.; Gatell, J.; Gazzard, B.; d’Arminio Monforte, A.; Rockstroh, J.; Yazdanpanah, Y.; Champenois, K.; Jakobsen, M. L.; Sullivan, A.; Lundgren, J. D. More authors...

Cite this document

Raben, D., Mocroft, A., Rayment, M., Mitsura, V. M., Hadziosmanovic, V., Sthoeger, Z. M. ... Lundgren, J. D. (2015). Auditing HIV testing rates across Europe: results from the HIDES 2 Study. PLoS ONE, 10. (11). doi: 10.1371/journal.pone.0140845

Raben, D., et al. "Auditing HIV testing rates across Europe: results from the HIDES 2 Study." PLoS ONE, vol. 10, no. 11, 2015. https://doi.org/10.1371/journal.pone.0140845

Raben, D., A. Mocroft, M. Rayment, V. M. Mitsura, V. Hadziosmanovic, Z. M. Sthoeger, A. Palfreeman, et al. "Auditing HIV testing rates across Europe: results from the HIDES 2 Study." PLoS ONE 10, no. 11 (2015). https://doi.org/10.1371/journal.pone.0140845

Raben, D., et al. (2015) 'Auditing HIV testing rates across Europe: results from the HIDES 2 Study', PLoS ONE, 10(11). doi: 10.1371/journal.pone.0140845

Raben D, Mocroft A, Rayment M, Mitsura VM, Hadziosmanovic V, Sthoeger ZM, and sur.. Auditing HIV testing rates across Europe: results from the HIDES 2 Study. PLoS ONE [Internet]. 2015 November 11 [cited 2024 July 10];10(11). doi: 10.1371/journal.pone.0140845

D. Raben, et al., "Auditing HIV testing rates across Europe: results from the HIDES 2 Study", PLoS ONE, vol. 10, no. 11, November 2015. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:804805. [Accessed: 10 July 2024]

Please login to the repository to save this object to your list.
Metadata
Title (english)Auditing HIV testing rates across Europe: results from the HIDES 2 Study
AuthorD. Raben
AuthorA. Mocroft
AuthorM. Rayment
AuthorV. M. Mitsura
AuthorV. Hadziosmanovic
AuthorZ. M. Sthoeger
AuthorA. Palfreeman
AuthorS. Morris
AuthorG. Kutsyna
AuthorA. Vassilenko
AuthorJ. Minton
AuthorC. Necsoi
AuthorV. P. Estrada
AuthorA. Grzeszczuk
AuthorV. Svedhem Johansson
AuthorJosip Begovac
AuthorE. L. C. Ong
AuthorA. Cabié
AuthorF. Ajana
AuthorB. M. Celesia
AuthorF. Maltez
AuthorM. Kitchen
AuthorL. Comi
AuthorU. B. Dragsted
AuthorN. Clumeck
AuthorJ. Gatell
AuthorB. Gazzard
AuthorA. d’Arminio Monforte
AuthorJ. Rockstroh
AuthorY. Yazdanpanah
AuthorK. Champenois
AuthorM. L. Jakobsen
AuthorA. Sullivan
AuthorJ. D. Lundgren
Author's institutionUniversity of Zagreb
School of Medicine
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Clinical Medical Sciences
Abstract (english)
European guidelines recommend the routine offer of an HIV test in patients with a number of AIDS-defining and non-AIDS conditions believed to share an association with HIV; so called indicator conditions (IC). Adherence with this guidance across Europe is not known. We audited HIV testing behaviour in patients accessing care for a number of ICs. Participating centres reviewed the case notes of either 100 patients or of all consecutive patients in one year, presenting for each of the following ICs: tuberculosis, non-Hodgkins lymphoma, anal and cervical cancer, hepatitis B and C and oesophageal candidiasis. Observed HIV-positive rates were applied by region and IC to estimate the number of HIV diagnoses potentially missed. Outcomes examined were: HIV test rate (% of total patients with IC), HIV test accepted (% of tests performed/% of tests offered) and new HIV diagnosis rate (%). There were 49 audits from 23 centres, representing 7037 patients. The median test rate across audits was 72% (IQR 32-97), lowest in Northern Europe (median 44%, IQR 22-68%) and highest in Eastern Europe (median 99%, IQR 86-100). Uptake of testing was close to 100% in all regions. The median HIV+ rate was 0.9% (IQR 0.0-4.9), with 29 audits (60.4%) having an HIV+ rate >0.1%. After adjustment, there were no differences between regions of Europe in the proportion with >0.1% testing positive (global p = 0.14). A total of 113 patients tested HIV+. Applying the observed rates of testing HIV+ within individual ICs and regions to all persons presenting with an IC suggested that 105 diagnoses were potentially missed. Testing rates in well-established HIV ICs remained low across Europe, despite high prevalence rates, reflecting missed opportunities for earlier HIV diagnosis and care. Significant numbers may have had an opportunity for HIV diagnosis if all persons included in IC audits had been tested.
Keywords (english)
Languageenglish
Publication typeScientific paper - Original scientific paper
Publication statusPublished
Peer reviewPeer review
Publication versionPublished version
Journal titlePLoS ONE
Numberingvol. 10, no. 11, e0140845
p-ISSN1932-6203
DOIhttps://doi.org/10.1371/journal.pone.0140845
URN:NBNurn:nbn:hr:105:804805
Publication2015-11-11
Document URLhttps://doi.org/10.1371/journal.pone.0140845
Type of resourceText
Access conditionsOpen access
Terms of useLicence In copyright icon
Created on2024-03-28 08:34:51